Frailty and Longitudinal Physiologic Outcomes in Older Patients with Idiopathic Pulmonary Fibrosis

被引：0
|
作者：
Sheth, J. S. [1 ]
Xia, M. [2 ]
Wang, Y. [2 ]
Murray, S. [2 ]
Meldrum, C. A. [1 ]
Belloli, E. A. [1 ]
Salisbury, M. L. [1 ]
White, E. S. [1 ]
Holtze, C. H. [1 ]
Wang, B. [1 ]
Flaherty, K. R. [1 ]
机构：
[1] Univ Michigan, Div Pulm & Crit Care Med, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2019年 / 199卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A7133
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Longitudinal "Real-World" Outcomes of Pirfenidone in Idiopathic Pulmonary Fibrosis in Greece
    Tzouvelekis, Argyrios
    Karampitsakos, Theodoros
    Ntolios, Paschalis
    Tzilas, Vasilios
    Bouros, Evangelos
    Markozannes, Evangelos
    Malliou, Ioanna
    Anagnostopoulos, Aris
    Granitsas, Andreas
    Steiropoulos, Paschalis
    Dimakou, Katerina
    Chrysikos, Serafeim
    Koulouris, Nikolaos
    Bouros, Demosthenes
    FRONTIERS IN MEDICINE, 2017, 4 : 1 - 1
  • [22] Outcomes in Patients Receiving Nintedanib or Pirfenidone for Idiopathic Pulmonary Fibrosis
    Cottin, V.
    Spagnolo, P.
    Bonniaud, P.
    Nolin, M.
    Dalon, F.
    Kirchgassler, K.
    Chia, J.
    Kamath, T. V.
    Van Ganse, E.
    Belhassen, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [23] Environmental Health and Clinical Outcomes in Patients with Idiopathic Pulmonary Fibrosis
    Avitzur, N.
    Noth, E. M.
    Lamidi, M.
    Nathan, S. D.
    Dedent, A. M.
    Thakur, N.
    Johannson, K. A. M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [24] Surgical treatment for patients with idiopathic pulmonary fibrosis and lung cancer: postoperative acute exacerbation of idiopathic pulmonary fibrosis and outcomes
    Akira Iyoda
    Yoko Azuma
    Susumu Sakamoto
    Sakae Homma
    Atsushi Sano
    Surgery Today, 2022, 52 : 736 - 744
  • [25] Clinical features and outcomes of 210 patients with idiopathic pulmonary fibrosis
    Cai Miaotian
    Zhu Min
    Ban Chengjun
    Su Jin
    Ye Qiao
    Liu Yan
    Zhao Wen
    Wang Chen
    Dai Huaping
    CHINESE MEDICAL JOURNAL, 2014, 127 (10) : 1868 - 1873
  • [26] Clinical features and outcomes of 210 patients with idiopathic pulmonary fibrosis
    Cai Miaotian
    Zhu Min
    Ban Chengjun
    Su Jin
    Ye Qiao
    Liu Yan
    Zhao Wen
    Wang Chen
    Dai Huaping
    中华医学杂志（英文版）, 2014, 127 (10) : 1868 - 1873
  • [27] Surgical treatment for patients with idiopathic pulmonary fibrosis and lung cancer: postoperative acute exacerbation of idiopathic pulmonary fibrosis and outcomes
    Iyoda, Akira
    Azuma, Yoko
    Sakamoto, Susumu
    Homma, Sakae
    Sano, Atsushi
    SURGERY TODAY, 2022, 52 (05) : 736 - 744
  • [28] Autoimmunity to Vimentin Is Associated with Outcomes of Patients with Idiopathic Pulmonary Fibrosis
    Li, Fu Jun
    Surolia, Ranu
    Li, Huashi
    Wang, Zheng
    Kulkarni, Tejaswini
    Liu, Gang
    de Andrade, Joao A.
    Kass, Daniel J.
    Thannickal, Victor J.
    Duncan, Steven R.
    Antony, Veena B.
    JOURNAL OF IMMUNOLOGY, 2017, 199 (05): : 1596 - 1605
  • [29] Outcomes in patients receiving nintedanib or pirfenidone for idiopathic pulmonary fibrosis
    Cottin, Vincent
    Spagnolo, Paolo
    Bonniaud, Philippe
    Nolin, Maeva
    Dalon, Faustine
    Chia, Jenny
    Kirchgassler, Klaus
    Kamath, Tripthi
    Van Ganse, Eric
    Belhassen, Manon
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 121 - 121
  • [30] Clinical characteristics, comorbidities, and outcomes in patients with idiopathic pulmonary fibrosis
    Alhamad, Esam H.
    Cal, Joseph G.
    Alrajhi, Nuha N.
    Aharbi, Waleed M.
    AlRikabi, Ammar C.
    AlBoukai, Ahmad A.
    ANNALS OF THORACIC MEDICINE, 2020, 15 (04) : 208 - 214
12345